TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism

Cell

Volumn 114, Issue 2, 2003, Pages 171-180

  Seo, Dong Wan ^a   Li, Hongmei ^a   Guedez, Liliana ^a   Wingfield, Paul T ^b   Diaz, Tere ^a   Salloum, Rita ^a   Wei, Bei Yang ^a   Stetler Stevenson, William G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Natl Institutes Arthr M   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; INTEGRIN; MATRIX METALLOPROTEINASE; PROTEIN SUBUNIT; PROTEIN TYROSINE PHOSPHATASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TYROSINE KINASE RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL;

EID: 0042197340     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00551-8     Document Type: Article

References (39)

1. Baker A.H., Edwards D.R., Murphy G. Metalloproteinase inhibitors. biological actions and therapeutic opportunities J. Cell Sci. 115:2002;3719-3727.
2. Baker A.H., George S.J., Zaltsman A.B., Murphy G., Newby A.C. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br. J. Cancer. 79:1999;1347-1355.
3. Barazi H.O., Zhou L., Templeton N.S., Krutzsch H.C., Roberts D.D. Identification of heat shock protein 60 as a molecular mediator of alpha 3 beta 1 integrin activation. Cancer Res. 62:2002;1541-1548.
4. Bousquet C., Delesque N., Lopez F., Saint-Laurent N., Esteve J.P., Bedecs K., Buscail L., Vaysse N., Susini C. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1. J. Biol. Chem. 273:1998;7099-7106.
5. Brautigan D.L., Shriner C.L. Methods to distinguish various types of protein phosphatase activity. Corkin J.D., Johnson R.A. Methods in Enzymology. 1988;Academic Press, Inc, New York. 339-342.pp.
6. Brooks P.C., Stromblad S., Sanders L.C., vonSchalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., Cheresh D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 85:1996;683-693.
7. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:2000;389-395.
8. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
9. Coussens L.M., Fingleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer. trials and tribulations Science. 295:2002;2387-2392.
10. Emmert-Buck M.R., Emonard H.P., Corcoran M.L., Krutzsch H.C., Foidart J.M., Stetler-Stevenson W.G. Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett. 364:1995;28-32.
11. Fassler R., Pfaff M., Murphy J., Noegel A.A., Johansson S., Timpl R., Albrecht R. Lack of beta 1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts. J. Cell Biol. 128:1995;979-988.
12. Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson W.G., Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 277:1997;225-228.
13. Guedez L., Mansoor A., Birkedal-Hansen B., Lim M.S., Fukushima P., Venzon D., Stetler-Stevenson W.G., Stetler-Stevenson M. Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. Blood. 97:2001;1796-1802. a.
14. Guedez L., McMarlin A.J., Kingma D.W., Bennett T.A., Stetler-Stevenson M., Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. Am. J. Pathol. 158:2001;1207-1215. b.
15. Guedez L., Rivera A.M., Miller M.L., Diegmueller J.J., Bungay P.M., Stetler-Stevenson W.G. Quantitative assessment of angiogenic responses by the drected in vivo angiogenesis assay (DIVAA). Am. J. Pathol. 162:2003;1431-1439.
16. Guedez L., Stetler-Stevenson W.G., Wolff L., Wang J., Fukushima P., Mansoor A., Stetler-Stevenson M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Invest. 102:1998;2002-2010.
17. Guo D.Q., Wu L.W., Dunbar J.D., Ozes O.N., Mayo L.D., Kessler K.M., Gustin J.A., Baerwald M.R., Jaffe E.A., Warren R.S., Donner D.B. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. J. Biol. Chem. 275:2000;11216-11221.
18. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
19. Hoegy S.E., Oh H.R., Corcoran M.L., Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J. Biol. Chem. 276:2001;3203-3214.
20. Imren S., Kohn D.B., Shimada H., Blavier L., DeClerck Y.A. Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res. 56:1996;2891-2895.
21. Jiang Y., Goldberg I.D., Shi Y.E. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 21:2002;2245-2252.
22. Jiang Y.F., Wang M.S., Celiker M.Y., Liu Y.E., Sang Q.X.A., Goldberg I.D., Shi Y.E. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res. 61:2001;2365-2370.
23. Keilhack H., Tenev T., Nyakatura E., Godovac-Zimmermann J., Nielsen L., Seedorf K., Bohmer F.-D. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling. J. Biol. Chem. 273:1998;24839-24846.
24. Lau K.-H.W., Farley J.R., Baylink D.J. Phophotyrosyl protein phosphatases. Biochem. J. 257:1989;23-26.
25. Maeshima Y., Sudhakar A., Lively J.C., Ueki K., Kharbanda S., Kahn C.R., Sonenberg N., Hynes R.O., Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science. 295:2002;140-143.
26. Murphy A.N., Unsworth E.J., Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157:1993;351-358.
27. Nakagami H., Cui T.X., Iwai M., Shiuchi T., Takeda-Matsubara Y., Wu L., Horiuchi M. Tumor necrosis factor-alpha inhibits growth factor mediated cell proliferation through SHP-1 activation in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 22:2002;238-242.
28. Perollet C., Han Z.C., Savona C., Caen J.P., Bikfalvi A. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood. 91:1998;3289-3299.
29. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., Baker A., Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3). inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 Nat. Med. 9:2003;407-415.
30. Rehn M., Veikkola T., Kukk-Valdre E., Nakamura H., Ilmonen M., Lombardo C., Pihlajaniemi T., Alitalo K., Vuori K. Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA. 98:2001;1024-1029.
31. Stupack D.G., Cheresh D.A. ECM remodeling regulates angiogenesis. endothelial integrins look for new ligands. Science's STKE:2002;;2002/119/pe7, http://www.stke.sciencemag.org/cgi/content/full/OC_sigtrans.
32. Sugiura T., Berditchevski F. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J. Cell Biol. 146:1999;1375-1389.
33. Tartaglia M., Fragale A., Battaglia P.A. A competitive PCR-based method to measure human fibroblast growth factor receptor 1-4 (FGFR1-4) gene expression. DNA Cell Biol. 20:2001;367-379.
34. Tarui T., Miles L.A., Takada Y. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J. Biol. Chem. 276:2001;39562-39568.
35. Tonks N.K., Neel B.G. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13:2001;182-195.
36. Wei Y., Eble J.A., Wang Z., Kreidberg J.A., Chapman H.A. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol. Biol. Cell. 12:2001;2975-2986.
37. Wennerberg K., Armulik A., Sakai T., Karlsson M., Fassler R., Schaefer E.M., Mosher D.F., Johansson S. The cytoplasmic tyrosines of integrin subunit beta1 are involved in focal adhesion kinase activation. Mol. Cell. Biol. 20:2000;5758-5765.
38. Wingfield P.T., Sax J.K., Stahl S.J., Kaufman J., Palmer I., Chung V., Corcoran M.L., Kleiner D.E., Stetler-Stevenson W.G. Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. J. Biol. Chem. 274:1999;21362-21368.
39. Yanez-Mo M., Alfranca A., Cabanas C., Marazuela M., Tejedor R., Ursa M.A., Ashman L.K., de Landazuri M.O., Sanchez-Madrid F. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J. Cell Biol. 141:1998;791-804.